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Imaging tumour cell heterogeneity following cell
transplantation into optically clear immune-
deficient zebrafish
Qin Tang1,2, John C. Moore1,2, Myron S. Ignatius1,2, Ineˆs M. Tenente1,2,3, Madeline N. Hayes1,2, Elaine G. Garcia1,2,
Nora Torres Yorda´n1,2, Caitlin Bourque4,5, Shuning He2,6, Jessica S. Blackburn1,2,7, A. Thomas Look2,6,
Yariv Houvras4,5 & David M. Langenau1,2
Cancers contain a wide diversity of cell types that are defined by differentiation states,
genetic mutations and altered epigenetic programmes that impart functional diversity to
individual cells. Elevated tumour cell heterogeneity is linked with progression, therapy
resistance and relapse. Yet, imaging of tumour cell heterogeneity and the hallmarks of
cancer has been a technical and biological challenge. Here we develop optically clear
immune-compromised rag2E450fs (casper) zebrafish for optimized cell transplantation and
direct visualization of fluorescently labelled cancer cells at single-cell resolution.
Tumour engraftment permits dynamic imaging of neovascularization, niche partitioning of
tumour-propagating cells in embryonal rhabdomyosarcoma, emergence of clonal dominance
in T-cell acute lymphoblastic leukaemia and tumour evolution resulting in elevated growth
and metastasis in BRAFV600E-driven melanoma. Cell transplantation approaches using
optically clear immune-compromised zebrafish provide unique opportunities to uncover
biology underlying cancer and to dynamically visualize cancer processes at single-cell
resolution in vivo.
DOI: 10.1038/ncomms10358 OPEN
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T
he conversion of phenotypically normal cells into
malignant cells is often associated with acquired ‘hallmarks
of cancer’ including elevated growth potential, suppression
of cell death pathways, development of new vascular networks
to feed the growing tumour and acquired cell motility that lead to
invasion and metastasis1,2. Despite our increased understanding
that cancer is driven by molecular changes that convert normal
cells into malignant cells, it has become well recognized that
not all cancer cells are created equal. For example, the process
of clonal evolution that is responsible for initiating cancer is also
a critical driver of intra-tumoral heterogeneity that is
constantly arising throughout the lifespan of a cancer cell3. This
heterogeneity provides a rich diversity of cell types and mutations
on which natural selection can act, ultimately leading to a
subset of cancers that elevate metastatic potential and therapy
resistance4–6. Despite our new found ability to genetically map
individual mutations that are acquired during tumour cell
evolution and progression7–9, it is been difficult to directly
visualize how these mutations affect tumour growth in live
animals. Access to optically clear animal models would permit the
dynamic visualization of the cancer hallmarks and provide
unprecedented access to dissect the molecular underpinnings of
cancer progression at single-cell resolution.
Over the past two decades, the field of cancer research has been
empowered by intra-vital imaging (IVM) in mouse models10,11.
Refined imaging tools, including confocal, multi-photon and light
sheet microscopy, have now been applied to a wide range of
cancers to facilitate the discovery of underlying mechanisms that
drive cancer growth in vivo. For example, Kedrin et al. have
utilized photoactivatable fluorescent proteins and cell lineage
tracing to visualize the tumour cell niche in mammary carcinoma.
These studies uncovered that cells adjacent to the vasculature
drive invasion and metastasis12. Using similar approaches,
Calabrese et al. discovered that Nestinþ brain tumour stem
cells reside in a perivascular niche13. Metastasis has also been
observed using IVM. For example, a single extravasated C26
colorectal cancer cell has been shown to proliferate and to
produce highly mobile pre-metastatic lesions in the liver14.
Sophisticated fluorescent labelling techniques, including cell
lineage tracing using Confetti and brainbow constructs15,16,
have now been successfully integrated with high-resolution
microscopy to visually dissect intra-tumoral heterogeneity.
For example, Zomer et al. utilized the Confetti strategy to
label individual mammary tumour cells, and performed proof-
of-concept experiments to show that tumour stem cells can
become alternatively active or quiescent during tumour
development17. Despite these successes, challenges presented by
the opacity of furred rodents, and the requirement for invasive
surgical implantation of imaging windows have limited the
application of IVM. Furthermore, requirements of imaging
through pre-defined windows often prohibit simultaneous
observation of tumour cells from the primary and metastatic
sites within the same animal.
Zebrafish have been developed as a robust model of human
cancer and have now been widely used for visualizing
cancer processes in live animals. For example, our group has
used fluorescent transgenic approaches to label embryonal
rhabdomyosarcoma (ERMS) cells based on differentiation status.
Using these approaches, we have been able to dynamically
visualize tumour cell heterogeneity in vivo, identifying
the existence of a molecularly defined tumour-propagating cell
(TPC) that expresses myf5-GFP and other differentiated cell types
that express myogenin and drive invasion18. Others have utilized
cell transplantation into irradiated, optically clear casper strain
adult zebrafish to visualize melanoma invasion19, and conversion
of T-lymphoblastic lymphoma into leukaemia20. Importantly,
these initial successes utilized cell transplantation into either
syngeneic strains of zebrafish or irradiated recipient animals
that only transiently dampen immune responses. Using
genome-editing approaches21, our group has recently developed
homozygous rag2E450fs zebrafish. These fish are viable as adults,
have deficiencies in T and B cells, and enable robust engraftment
of fluorescently labelled zebrafish tumour cells from a wide range
of cancers and strains of zebrafish22. Despite the utility of the
rag2E450fs model for cell engraftment studies, the rag2E450fs
mutation was created on the pigmented AB-strain and thus it
has been difficult to image tumour cells at single-cell resolution in
engrafted animals.
Here we create transparent casper strain, rag2E450fs mutant
zebrafish and utilize these animals for transplantation studies
to image heterogeneity and various ‘hallmarks of cancer’.
For example, confocal imaging permits the dynamic visualization
of TPCs in ERMS and the emergence of clonal dominance in
T-cell acute lymphoblastic leukaemia (T-ALL). Serial imaging
studies also detail the evolution of metastasis in a subset
of BRAFV600E-driven melanomas and facilitate the direct
visualization of micro-metastatic disease. Our work provides a
universal transplantation model for imaging cancer cell processes,
opening new avenues for visualizing the functional consequences
of cancer cell heterogeneity and clonal evolution at single-cell
resolution in the zebrafish.
Results
Engraftment of allogeneic tumours. We have previously
reported the production of lymphocyte-deficient rag2E450fs
mutant zebrafish that engraft a wide variety of normal and
malignant zebrafish cells22 (ZFIN allele rag2fb101). However, these
initial studies utilized pigmented, AB-strain zebrafish, making it
difficult to directly visualize tumour cells at high resolution
in vivo. To facilitate imaging of cancer in live zebrafish, the
rag2E450fs mutation was bred into the casper background—a
transparent zebrafish that lacks melanocytes and iridophores19.
As expected, rag2E450fs (casper) zebrafish efficiently engrafted
fluorescently labelled T-ALL23, neuroblastoma24, ERMS18,25 and
melanoma26,27 (Fig. 1, Supplementary Fig. 1 and Supplementary
Table 1). Tumours derived from CG1, AB and nacre
strain zebrafish engrafted efficiently into rag2E450fs (casper)
zebrafish and did not require matching at the major
histocompatibility complex or pre-conditioning with
g-irradiation. Importantly, engrafted tumours exhibited similar
histology as donor tumours (Fig. 1). As has been reported
previously for AB-strain wild-type transplant recipients22,
tumours failed to engraft into unconditioned casper-strain
animals that have an intact rag2 locus (Supplementary Table 1
and Supplementary Fig. 1).
Visualizing the dynamics of tumour neovascularization.
Neovascularization is an important hallmark of cancer and has
been imaged in a variety of cancers18,28,29. To assess the utility
of adult rag2E450fs (casper) fish for imaging neovascularization
in the transplantation setting, green fluorescent protein (GFP)-
labelled BRAFV600E, tp53 / amelanotic melanoma27 cells were
implanted into the dorsal musculature of 3-month-old rag2E450fs
(casper) fish (5 105 cells in 2ml per animal). Because
engraftment was initially limited to the dorsal musculature,
melanomas developed adjacent to the skin epidermis.
Neovascularization could be directly visualized by confocal
microscopy following injection of crimson quantum dots30 into
the blood stream at 25 days post transplantation (d.p.t.; Fig. 2a,
n¼ 8 animals). Crimson quantum dots were chosen because they
excite in far-red wavelengths and can be easily differentiated from
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other fluorescent proteins used to label tumour cells in this study,
including AmCyan, GFP, ZsYellow, DsRED and mCherry. To
further refine imaging of neovascularization within solid tumours,
we next created flk1:mCherry; rag2E450fs (casper) fish with
fluorescently labelled vasculature. Animals were injected intra-
muscularly with GFP-labelled melanoma (5 105 cells in 2 ml per
animal). Following successful engraftment at the site of injection,
vessels were readily visualized by confocal microscopy ( 100
magnification, 105.71 mm¼ 10 z-stacks, n¼ 4 animals, Fig. 2b).
Finally, we have been able to visualize how neovascularization
changes over time within the same animal, which results in the
creation of dense vascular networks associated with ERMS growth
( 100 magnification, 223.64 mm¼ 10 z-stacks, Fig. 2c,d).
Together, these experiments demonstrate the ease and utility of
ERMS
(CG1)
Neuroblastoma
(AB)
T-ALL
(CG1)
Melanoma
(nacre)
AB Casper
Donor rag2E450fs recipients
Figure 1 | Zebrafish cancers engraft into homozygous rag2E450fs (casper) animals. Donor animals shown in the left two panels while transplant recipients
are to the right. (a) ZsYellow-labelled Myc-driven T-ALL from the syngeneic CG1 background, (b) EGFP-labelled neuroblastoma from AB background,
(c) mCherry-labelled kRASG12D-driven ERMS from CG1 background, and (d) BRAFV600E-induced melanoma arising in tp53 /nacre background. Tumour
cells were transplanted intra-peritoneally (a,b,d) or intra-muscularly (c) into both rag2E450fs (AB) and rag2E450fs (casper)-recipient fish. Merged brightfield
and fluorescent images are shown at 30 d.p.t. Cytospins of leukaemia cells are shown in a, whereas haematoxylin and eosin (H&E)-stained sections are
shown in b–d. Scale bars equal 5mm in whole animals images, 20mm for cytospins shown in a, and 50mm for histology sections shown in b–d.
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Figure 2 | Imaging neovascularization in rag2E450fs (casper) zebrafish engrafted with fluorescently labelled melanoma and ERMS. (a) GFP-labelled,
amelanotic melanoma implanted into rag2E450fs (casper) fish (n¼ 8 animals) and imaged following intravascular injection of crimson quantum dots
(Qtracker 655). Whole animal images to the left and confocal images to the right ( 100 magnification, 100–200mm z-stack). Quantum dot fluorescence
has been pseudo-coloured white. (b) GFP-labelled, amelanotic melanoma implanted into flk1:mCherry; rag2E450fs (casper) transgenic zebrafish (n¼4
animals). (c–d) GFP-labelled ERMS engrafted into flk1:mCherry; rag2E450fs (casper) transgenic zebrafish (n¼ 5 animals) and serially imaged over time (c, 13
d.p.t. and d, 21 d.p.t.). White arrowheads denote the site of intra-muscular injection of tumour cells. Scale bars equal 5mm in whole animal images and
200mm in confocal images.
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imaging neovascularization in solid tumours using the rag2E450fs
(casper) fish.
Imaging ERMS heterogeneity at single-cell resolution. We next
wanted to dynamically visualize tumour cell heterogeneity at
single-cell resolution using a transgenic model of kRASG12D-
driven ERMS25. We have previously created primary ERMS
in triple transgenic myf5:GFP; myogenin-H2b:mRFP;
mylpfa:lyn-cyan zebrafish, which enables the labelling of
tumour cells based on differentiation status18. To achieve direct
imaging of heterogeneous tumour cell populations in
adult zebrafish, we engrafted these fluorescent transgenic
ERMS by intra-muscular injection into 3-month-old adult
flk1:mCherry; rag2E450fs (casper) strain zebrafish (4 105 cells in
2 ml per animal, Fig. 3a,b). Confocal microscopic imaging
revealed that GFP-labelled TPCs and AmCyan-labelled
differentiated cells were largely confined to distinct regions of
the tumour ( 100 magnification, Fig. 3c, left panel), consistent
with previous reports18. Remarkably, the vasculature transects
areas of regional tumour cell heterogeneity. We have also
noted that in this particular case, juxtaposition of specific
ERMS cell subtypes near vascular beds was not observed.
Higher magnification imaging of areas enriched with
differentiated ERMS cells revealed the presence of myf5-GFPþ
TPCs, albeit at reduced numbers when compared with other
regions of the tumour ( 400 magnification, Fig. 3c, right panel).
Our data suggest that ERMS cells largely reside in regionally
defined niches based on differentiation status and are not
anatomically confined by proximity to vessels. The
combination of fluorescent transgenic labelling of tumour cell
subpopulations and subsequent cell transplantation will be
important for defining how niche topology is established and
ultimately influences continued tumour growth in ERMS and a
wide range of cancers.
Detailing emergence of clonal dominance in T-ALL. We next
wanted to use our model to dynamically visualize the functional
consequences of tumour cell heterogeneity and emergence of
clonal dominance in T-ALL. It is well known that human
leukaemias and myelomas are oligoclonal at diagnosis; however,
relapse is often driven by emergence of an underrepresented
clone contained within the primary malignancy31–35. We have
previously created Myc-induced T-ALLs that express a variety of
fluorescent proteins and then used cell transplantation to create
T-ALLs derived from single leukaemia cells36. Using these
monoclonal T-ALLs, our experiments sought to dynamically
visualize how individual T-ALL clones grow when combined
together, testing the hypothesis that inherent functional
differences between cells drive the emergence of clonal
dominance.
First, we assessed the kinetics of leukaemia regrowth in clones
that exhibited wide differences in leukaemia-propagating cell
(LPC) frequency and latency. Specifically, we mixed equal
numbers of AmCyan, ZsYellow and DsRED-labelled cells isolated
from three independent T-ALLs (Supplementary Fig. 2a–c).
Following transplantation into the dorsal musculature (3.3 104
of each clone, 1.0 105 total cells per recipient animal), engrafted
fish were imaged by confocal microscopy at 14 and 25 d.p.t.
Consistent with our expectations, ZsYellow-labelled T-ALL cells
with the highest LPC frequency and fastest growth outcompeted
the other clones at each of the time points analysed, making up
48.7% of the leukaemia by 14 d.p.t. and 72.3% by 25 d.p.t.
(Supplementary Fig. 2d,e). These data suggest that clonal
dominance can result from inherent functional differences
between clones.
We next wanted to examine emergence of clonal dominance in
T-ALL that had similar LPC frequency and growth kinetics,
exploring the notion that clonal dominance may also emerge
stochastically in vivo. For example, Lgr5þ intestinal crypt stem
cells exhibit a pattern of neutral drift, ultimately resulting in
Donor
Recipient
flk1:mCherry;
rag2E450fs
(casper)
TPC
Diff.
flk1:mCherry; rag2E450fs
myogenin-H2b-mRFPmylpfa-lyn-cyanmyf5-GFP
Figure 3 | Resolving tumour cell heterogeneity in ERMS at single-cell resolution following engraftment into flk1:mCherry; rag2E450fs (casper) zebrafish.
(a) Epi-fluorescent images of primary ERMS in a 32-day-old myf5:GFP; myogenin-H2b:mRFP; mylpfa:lyn-cyan triple transgenic zebrafish. (b) Epi-fluorescent
images of flk1:mCherry; rag2E450fs (casper)-recipient fish engrafted intra-muscularly with fluorescently labelled ERMS at 28 d.p.t. (n¼4 animals). (c)
Confocal image with mCherry-labelled vasculature outlined by white dashed lines (left,  100 magnification). Higher magnification of boxed region (right,
400 magnification). Myosin-expressing, differentiated cells (Diff.) and less frequent myf5-GFPþ tumour-propagating cell (TPC) denoted by arrowheads.
Scale bar equals 2mm in a, 5mm in b, 100mm (c, left panel) and 25mm (c, right panel).
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regional dominance of a single clone within each villus37. In the
cancer setting, elegant cell lineage tracing experiments have
confirmed that clonal drift can impart regional dominance of
Lgr5þ intestinal crypt stem cells in mouse intestinal
adenomas38. To assess if clonal drift may also account for
dominance of T-ALL clones over time, T-ALL clones that had
similar growth rates and LPC frequencies were transplanted into
recipient rag2E450fs (casper) fish (3.3 104 of each clone, 1.0 105
total cells per recipient animal). Despite these leukaemias having
similar growth rates, latency and LPC frequencies (Fig. 4a–c), the
AmCyanþ clone was consistently outcompeted over time,
comprising only 9.8±6.4% of the leukaemia by 22–24 d.p.t.
(Fig. 4d,e). By contrast, the remaining leukemias contained both
mCherryþ and ZsYellowþ cells and in some instances
dominance of one clone prevailed (Fig. 4f, n¼ 16 animals). To
rule out the potential effects of fluorescent labelling may have on
the proliferation of leukaemia cells, we repeated the same
experiment with another combination of AmCyan, ZsYellow
and mCherry T-ALL clones that also shared similar LPC
frequency and latency. Interestingly, with this combination, the
ZsYellow-labelled cells was reproducibly outcompeted by the
AmCyan- or mCherry-labelled cells, with dominance of these
latter clones being observed in animals over time (n¼ 13 animals
total, 2 independent experiments, Supplementary Fig. 3). We
conclude that clonal dominance can result from inherent genetic
and epigenetic differences between different tumour clones,
which was not revealed using traditional limiting dilution cell
transplantation approaches that only analyse the growth of
individual clonal populations of cells. Moreover, our experiments
provided additional evidence that neutral stochastic drift can
account for emergence of clonal dominance over time.
Tumour evolution and metastasis in melanoma. Metastasis is a
major clinical challenge for those diagnosed with melanoma and
is associated with poor prognosis39,40. Not all cancer cells can
enter the circulation and seed new areas of tumour growth,
suggesting that heterogeneity and continued clonal evolution
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Figure 4 | Visualizing the emergence of clonal dominance in Myc-induced T-ALL. (a) Donor animals engrafted with monoclonal T-ALL arising in the CG1
background. (b,c) Monoclonal T-ALLs were implanted into the syngeneic CG1 strain fish and assessed for LPC frequency by limiting dilution cell
transplantation (b) or latency of regrowth (c). P-values are noted within each panel. Not significant (NS). (d,e) Confocal imaging of engrafted rag2E450fs
(casper) fish at 10 d.p.t. (d) and 23 d.p.t. (e). White arrow denotes site of injection, and the location for confocal imaging. (f) Relative proportions of each
fluorescent clone contained within leukaemias from individual engrafted animals (n¼ 16 animals). Imaging was completed on the same animals at 10–13
d.p.t. and 22–24 d.p.t. The ZsYellowþ clone dominates leukaemia regrowth in animals #1–3, whereas mCherryþ dominates in animals #13–16. Scale bars
equal 5mm in whole animal images and 50mm in confocal images.
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likely drive metastasis in a large subset of cancers41. Yet, to date,
zebrafish models of bona fide metastatic progression have not
been fully described. To recapitulate metastasis in adult zebrafish,
we first transplanted melanoma cells retro-orbitally into the
recipient rag2E450fs (casper) fish. Robust engraftment was
observed at the site of injection, followed by local infiltration
into structures adjacent the gill, head kidney and kidney marrow
(Fig. 5a,b). Yet, with a stringent definition of metastasis, we could
not document a single case where metastasis originated from
haematogenous spread or was delineated by growth clearly
separated from the primary site.
To further refine methods to assess metastatic spread, we next
injected GFP-labelled, BRAFV600E, tp53 / melanoma cells into
the dorsal musculature of rag2E450fs (casper) zebrafish, reasoning
that infiltration into muscle would be clearly distinguished
from seeding of distant sites within the visceral organs. Using
this approach, three out of six primary melanomas metastasized
to structures near the thymus and head musculature that
were clearly distinct from the primary lesion (Fig. 5c and
Supplementary Table 2). In total, 8 of 58 engrafted animals
harboured distant metastasis by 30 d.p.t. (Supplementary
Table 2). Metastatic growth was easily quantified over time
following serial imaging of the same animal (Fig. 5d). GFPþ
metastatic lesions were independently confirmed by
histo-pathological analysis for morphology, pigmentation and
anti-GFP immunostaining on section (Fig. 5e). Using similar
approaches, we have also dynamically visualized metastatic
tumour growth in neuroblastoma and ERMS (Supplementary
Fig. 4), suggesting this approach will likely be broadly useful for
assessing the kinetics of metastatic colonization and growth in a
wide range of solid tumours.
We next wanted to assess how metastatic potential may change
in the same tumour over time and whether serial passaging of
individual melanomas could result in phenotypic changes,
including increased aggression, invasion and acquisition of
metastatic characteristics. Specifically, two non-metastatic
BRAFV600E, p53 / melanomas at the 1 passage were
implanted into the dorsal musculature of rag2E450fs (casper)
zebrafish and animals assessed for local engraftment, invasion
and metastatic growth following serial passaging. Sectioning and
microscopic analysis confirmed that early passaged melanomas
were not metastatic and tumours were confined to the site of
injection (Fig. 6a and Supplementary Fig. 5a). Following serial
passaging, one melanoma continued to resemble the parental
tumour and did not change its growth rate or metastatic potential
(8 passages, total 191 days in vivo, Supplementary Fig. 5b,c).
By contrast, the second melanoma lost pigmentation, had
significantly accelerated growth and harboured metastatic lesions
(7 passages, total 134 days in vivo, Fig. 6b,c). With this particular
tumour, GFPþ lesions were found to have metastasized to the
mesonephric trunk kidney by 6 d.p.t., which eventually spread to
the regions adjacent to the thymus and head kidney by 12 d.p.t.
Intramuscular transplantation: melanoma distal metastasis
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Figure 5 | Visualizing melanoma invasion and metastasis following engraftment into rag2E450fs (casper) mutant fish. (a) Invasion assays using retro-
orbital transplantation of a BRAFV600E, tp53 / pigmented melanoma. White arrow denotes the site of injection. Green arrow denotes spread to the
kidney marrow that is contiguous with primary tumour growth that has arisen adjacent to the eye. Histological examination confirmed the presence of
pigmented melanoma cells at the site of injection (b, left panels) and contiguous with the trunk kidney (b, right panels). (c) Metastasis assays using
implantation of non-pigmented, GFP-labelled melanoma cells into the dorsal musculature of rag2E450fs (casper)-recipient fish. White arrow denotes the site
of injection. Yellow arrow denotes site of distal metastasis. (d) Quantification of metastatic growth as assessed by epi-fluorescence microscopy over time.
(e) Haematoxylin and eosin-stained sections of the same animal imaged in c, confirming metastatic growth of melanoma adjacent to the thymus (top
panels) and confirmed by anti-GFP immunostaining on section (bottom panels). Scale bars equal 5mm for whole animal images, 2mm in images of heads,
1mm in 40 histological images; 300 mm in  100 histological images and 100mm in 400 histological images.
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(n¼ 4 of 4, P¼ 0.003, two-tailed Fisher’s exact test). Confocal
imaging revealed seeding of GFP-labelled cells to distal sites
within the tail of the recipient fish, suggesting the formation of
micro-metastatic lesions adjacent to flk1:mCherry-labelled
vasculature (n¼ 2, Fig. 6d). Our experiments confirm that not
all melanoma cells have metastatic capacity and that evolution of
metastatic potential occurs in melanoma, consistent with that
have been reported for human melanoma42,43. In total, our model
provides a dynamic imaging platform to visualize the tropism of
metastasis.
Discussion
Imaging cancer cell heterogeneity and the hallmarks of cancer in
live animals has been a challenge. Many investigators have
developed imaging modalities and complex surgical approaches
in rodent models to gain optical access to developing tumours.
These approaches often require implantation of imaging
windows for repeated high-resolution IVM10,11. Using these
experimental platforms, investigators have successfully
imaged several hallmarks of cancer, including migration44,
intravasation45, extravasation46, invasion47 and metastasis12,14,
as well as responses to chemotherapies in vivo48. In hope of
bypassing the need for surgical intervention and overcoming the
limitation of visualizing cancer cells only within predetermined
imaging windows, we engrafted fluorescently labelled cancers into
optically clear immune-compromised zebrafish and directly
imaged tumours using confocal microscopy. Engraftment of
fluorescent cancers into the rag2E450fs (casper) zebrafish has
facilitated the direct visualization of single cancer cells, functional
differences between tumour cell clones and several hallmarks of
cancer including acquisition of elevated growth potential,
development of new vascular networks and acquired cell
motility leading to invasion and metastasis.
The functional consequences of tumour cell heterogeneity have
only recently begun to be explored using IVM, and a number of
interesting and unexpected tumour cell behaviours have been
revealed. For example, our group has utilized fluorescent
transgenic approaches to label ERMS cells based on muscle
differentiation status18. Our experiments uncovered that
differentiated ERMS cells seed new areas of growth, followed
later by slow-moving, less-differentiated myf5þ TPCs,
challenging the notion that cancer stem cells drive invasion and
metastasis. Imaging approaches have not been limited to analysis
of primary tumours. Rather, Chapman et al. have used xenograft
cell transplantation of human melanoma cells into larval zebrafish
to assess the effects of intra-tumoral heterogeneity on growth49.
They found that tumours with high invasive capacity could
impart migratory potential to poorly invasive cell types.
Moreover, the poorly invasive cells could also enhance
colonization by aggressive melanomas when co-implanted into
larval fish, suggesting cell–cell cross-talk and collaborative
signalling networks can enhance migratory and invasive
behaviour between melanoma subclones. Using differential
labelling of human melanoma cells with GFP and mCherry,
these authors were able to dynamically image these processes in
live engrafted fish. Here, we performed proof-of-concept
experiments to assess the utility of rag2E450fs (casper) zebrafish
for visualizing engraftment of heterogeneous ERMS cells in live
animals. For example, we directly visualized niche partitioning
based on differentiation status using fluorescently labelled ERMS
cells. These niches are not anatomically confined by proximity to
vessels, in contrast to what has been observed in osteosarcoma50
and brain tumours13,51 where cancer stem cells lie in unique
niches adjacent vessels. Furthermore, cell transplantation into
orthotopic sites in the rag2E450fs (casper) zebrafish permitted
imaging of cells at single-cell resolution in live animals. We
envision that similar strategies will likely aid in assessing stromal
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Figure 6 | Assessing metastatic potential and the functional consequences of tumour evolution in melanoma. (a,b) Serial imaging of engrafted GFP-
labelled melanoma implanted into adult rag2E450fs (capser) mutant fish. The 1 transplant was pigmented (a), whereas the 7 transplanted melanoma had
lost pigmentation (b). Number of animals with metastatic growth is noted (*P¼0.003, Fisher’s exact test comparing 1 and 7 transplant). White arrow
indicates the site of injection. Yellow and red arrows denote sites of distal metastases. Histological staining (H&E and anti-GFP) of distal metastasis is
shown in the right panels. (c) Quantification of tumour growth at the site of initial engraftment over time. (d) Confocal imaging of micro-metastatic lesions
found adjacent to the tail vasculature of flk1:mCherry; rag2E450fs (casper)-recipient fish engrafted with 7 transplant melanoma. Yellow arrows denote micro-
metastatic lesions. Scale bars equal 5mm for whole animal images in a,b, 2mm for histology shown in a,b and 200mm in d.
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cell contributions to tumour growth. In total, our cell
transplantation and imaging approaches will likely facilitate
efforts in defining how niche topology is established and
ultimately influences continued tumour growth.
Evidence for continued clonal evolution and selection follow-
ing treatment has now been seen in a wide range of human
cancers. For example, human leukaemias and myelomas are
oligoclonal at diagnosis; however, relapse is commonly driven by
an underrepresented clone contained within the primary
malignancy31–35. Similar dynamics of heterogeneity has also
been observed in solid tumours. For example, triple-negative
breast cancers are comprised of heterogeneous clones that
harbour a wide spectrum of mutations that can change from
the time of diagnosis to relapse52,53. Altering frequencies of
specific clones have also been observed during tumour
progression in pancreatic cancer54,55 and brain tumours56.
Elegant cell lineage tracing experiments in mice have shown
experimentally that stochastic clonal drift can contribute to
regional dominance of Lgr5þ intestinal crypt stem cells in
mouse intestinal adenomas38; yet it is unclear if this pattern
applies to a wider array of cancer subtypes. Here, we have
experimentally recreated tumour cell heterogeneity by implanting
equal numbers of fluorescently labelled T-ALL clones into the
rag2E450fs (casper) zebrafish. By competing these T-ALL clones
together, we find that one clone was consistently outcompeted
over time despite having equal self-renewal potential and overall
growth kinetics. Our data suggest that subtle functional variations
can exist within clones that may not be uncovered using
traditional cell transplantation assays that assess tumour
regrowth of only single clones, likely underestimating
differences in latency and LPC frequency. Alternatively, these
data may suggest that clones actively suppress the growth of other
clones and/or secrete factors to enhance growth of only related
cells. This interpretation is consistent with recent findings in
breast cancer where paracrine factor signalling from one clone
can alter growth of unrelated clones within the tumour57. Taken
together, these in vivo competition experiments have uncovered
interesting and potentially new biology that could not have been
discovered using traditional limiting dilution cell transplantation
approaches, facilitating the dynamic emergence of clonal
dominance within the same animal overtime.
Metastasis can be experimentally assessed in mouse models by
engrafting tumour cells into the vasculature and then identifying
metastatic lesions at necropsy. Alternatively, luciferase biolumi-
nescent imaging and non-invasive, whole-body imaging methods
have also been developed, including computed X-Ray tomogra-
phy, positron emission tomography and magnetic resonance
imaging. These imaging modalities are limited to detection of
tumours that are 200mm in diameter, expensive and largely
inaccessible to many laboratories58–60. Here, we have optimized
cell transplantation into adult, immune-deficient rag2E450fs
(casper) zebrafish in order to dynamically visualize tumour cell
migration, invasion and metastasis at high resolution. We
performed cell transplantation of fluorescently labelled zebrafish
tumour into the optic vessels and dorsal musculature, establishing
that metastatic progression is best assessed following injection
into the dorsal musculature. Furthermore, we have been able to
visualize the dissemination of micro-metastatic lesions to sites
adjacent to the tail vasculature in flk1:mCherry; rag2E450fs (casper)
zebrafish using simple confocal imaging. Finally, using serial
transplantation, we were able to evolve melanomas with high
metastatic potential, providing a novel platform for identifying
driver mutations that are specifically correlated with progression.
We envision that facile genetic approaches including transgenesis
and genetic knock-out using CRISPR/Cas9 will quickly make
zebrafish the choice experimental model for assessing gene
pathways that modulate tumour progression and metastasis,
especially in the transplantation setting.
Methods
Creation of rag2E450fs (casper) homozygous mutant zebrafish. Zebrafish stu-
dies were approved by the Massachusetts General Hospital Subcommittee on
Research Animal Care (protocol #2011N000127).
rag2E450fs (casper) homozygous mutant zebrafish were created by crossing
rag2E450fs (rag2fb101) mutant fish into the casper background19. Animals were
maintained as rag2E450fs/þ ; roy / ; mitfa / lines and in-crossed to generate
triple mutant animals. Resulting progeny were fin clipped and genotyped using the
same method as we previously published22. Specifically, genomic DNA was
extracted using the Hotshot method described by Meeker et al.61, and subjected to
PCR using forward primer 50-ACTGCTCTAGTTGCAATTCCT-30 and reverse
primer 50-AGCTGGGGTCATCTTCAGT-30 . PCR was completed using 94 C
denaturation for 30 s, 54 C annealing for 30 s and 68 C elongation for 45 s
(35 cycles). PCR-amplified products were then incubated at 37 C overnight with
XcmI, which created a single cut in the mutant allele. Finally, DNA products were
resolved either on a 2% agarose gel or using the Qiaxcel genotyping system. For
neovascularization studies, flk1:mCherry transgenic fish62 were crossed with
rag2E450fs (casper) fish and in-crossed to create compound mutant animals.
Tumour creation and cell transplantation into zebrafish. Primary and serially
passaged tumours were derived from established transgenic zebrafish models. For
example, T-ALLs were created by co-microinjection of linearized rag2:cMyc and
fluorescent transgenic reporters into one-cell stage CG1 fish36,63 (Figs 1 and 4 and
Supplementary Figs 1–3). GFP-labelled ERMS were created by co-microinjection of
linearized rag2:kRASG12D and rag2:GFP transgenes into one-cell stage CG1 fish64
(Fig. 2); double-fluorescent ERMS were created by microinjection of linearized
rag2:kRASG12D into one-cell-stage stable transgenic myf5:GFP; mylpfa:mCherry
CG1 fish18 (Fig. 1 and Supplementary Fig. 4). Triple-fluorescent transgenic ERMSs
were created by microinjecting the linearized rag2:kRASG12D transgene into
one-cell stage stable transgenic myf5:GFP; myogenin-H2b:mRFP; mylpfa:lyn-cyan
zebrafish in the AB background (Fig. 3). Melanomas were created by
overexpression of MiniCoopR-EGFP in the embryos of Tg (mitfa:BRAFV600E);
mitfa / ; tp53 / or Tg (mitfa:BRAFV600E); mitfa / ; tp53 / ; alb /
zebrafish27 (Figs 1,2,5 and 6 and Supplementary Fig. 5), and were a kind gift from
the Houvras laboratory. The official ZFIN designation for the tp53 / zebrafish
line is zdf1M214K, originally reported by Berghmans et al.65. Neuroblastomas were a
kind gift from the Look laboratory24.
Cell transplantation experiments utilized both male and female rag2E450fs
(casper) homozygous mutant zebrafish. Recipient animals were transplanted at 2–4
months of age. Tumour cell transplantations were completed by intra-peritoneal,
intra-muscular and retro-orbital injections66–68. Intra-muscular and retro-orbital
injections were completed using microinjection of 2–3ml of cell suspension.
Recipient fish were scored for tumour engraftment, growth, invasion or metastasis
by epi-fluorescent microscopy every 3–4 days until 30 d.p.t. or when animals were
moribund.
Confocal imaging of neovascularization and micro-metastasis. rag2E450fs
(casper) animals were engrafted with GFP-labelled ERMS or melanoma. To
visualize tumour vasculature, animals were injected with Quantum dot 655 reagent
(Qtracker 655, 405–615 nm excitation, 655 nm emission, 2.0 mM, Life Technologies
Cat# Q21021MP). Specifically, animals were injected with freshly prepared 1:3
diluted reagent (1 volume Qtracker 655 solution diluted in 2 volumes of 0.9x PBS,
yielding a final concentration of 0.66 mM) using a 26s gauge Hamilton syringe
(4 ml injected intra-peritoneally, and 2 ml directly into the dorsal aorta). After
30min, animals were anaesthetized using 168mg l 1 Tricaine (MS-222, pH¼ 7.5)
and placed onto a 12.0-mm glass bottom imaging plate (Thermo Scientific, Cat#
150680). Under anaesthesia, motor functions of the animal were greatly reduced
and operculum movements were significantly slowed. Each animal was imaged
under anaesthesia for 1–2min, allowing enough time for z-stack imaging or
multi-position single plane imaging using confocal microscopy. To ensure optimal
survival of the adult zebrafish being imaged, anaesthetized animals were simply laid
down on the side in the imaging dish, with the tumour facing towards the lens. No
agarose embedding of the sample was used. Imaging was completed using an
inverted Zeiss LSM 710 confocal microscope. For neovascularization (Fig. 2) and
micro-metastasis imaging (Fig. 6d), z-stack imaging at  100 magnification was
achieved with a  10 objective (numerical aperture¼ 0.45, coverglass
thickness¼ 0.17mm, working distance¼ 2.0mm). Image series were acquired in
the ZEN software (single pass point scanning atB10mm per step over 100–200mm
distances). Fluorescent imaging was completed using the following settings: GFP:
excitation¼ 488 nm, emission¼ 503–528 nm; mCherry/mRFP: excitation¼ 561
nm, emission¼ 602–624 nm; Qtracker 655: use AlexaFlour647 setting,
excitation¼ 633 nm, emission¼ 638–755 nm. Laser intensity percentages were set
to be between 10 and 20% depending on the brightness of the fluorescent labels
used. The ‘Best Signal’ option in the ‘Smart Setup’ was used for easy modulation of
the gating of each colour. For imaging fluorescent combinations, gate settings were
manually adjusted to avoid overlap of fluorescent signals. For z-stack images,
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planes were merged based on maximum intensity in Fiji (ImageJ). After imaging,
fish were immediately transferred into recovery tanks that contained fresh system
water, and later returned to the facility.
Confocal imaging of heterogeneity in ERMS and T-ALL. Multi-colour confocal
fluorescence imaging was completed in both ERMS and T-ALL. Specifically, in
ERMS (Fig. 3) and T-ALL (Fig. 4 and Supplementary Figs 2,3), we simultaneously
imaged using three-colour combinations including AmCyan (excitation¼ 458 nm,
emission¼ 472–508 nm), GFP (excitation¼ 488 nm, emission¼ 493–586 nm),
ZsYellow (excitation¼ 514 nm, emission¼ 521–547 nm), DsRED (excitation¼
561 nm, emission¼ 575–703 nm) and mCherry/mRFP (excitation¼ 561 nm,
emission¼ 602–623 nm). Laser intensity percentages were set to be 18%. For
imaging at single-cell resolution,  400 magnification was achieved with a  40
water emersion objective (NA¼ 1.3, coverglass thickness¼ 0.14–0.19mm, working
distance¼ 0.62mm for 0.17mm coverglass). The ‘Best Signal’ option in the ‘Smart
Setup’ was used for easy modulation of the gating of each colour. For T-ALL,
proportions of each clone were quantified in the Fiji (ImageJ) software by measure
of area covered by each fluorescent colour (Fig. 4 and Supplementary Fig. 2,3f), or
manual cell counts (Supplementary Fig. 3g). Both quantification methods produce
consistently similar results.
Histological examination. Tumour histology was performed on animals as
previously described22. Briefly, animals were fixed in 4% paraformaldehyde,
embedded in paraffin and step sectioned. Adjacent slides were stained with
haematoxylin and eosin or anti-GFP (Living Colors Monoclonal Antibody JL-8,
Clontech, 1:1,000 dilution).
Statistical methods. Leukaemia propagating cell frequencies were calculated
using the extreme limiting dilution analysis software (http://bioinf.wehi.edu.au/
software/elda/). Differences in the LPC frequency were reported with a 95%
confidence interval. Differences of latency were assessed by log-rank (Mantel-Cox)
tests (Fig. 4 and Supplementary Figs 2,3). In the melanoma evolution experiments
(Fig. 6), increased metastatic potential was assessed by Fisher’s exact test,
comparing the number of animals with metastatic disease at 1 transplant with
those found after 7 transplant.
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